Hong Kong Stock Market Moves | DIAGENS-B Rises Over 10% in Afternoon Session Following Platform Launch and Partnership Deals

Stock News07-30

DIAGENS-B (02526) surged more than 10% in the afternoon, trading up 10.16% at HK$275.4 as of the time of writing, with a turnover of HK$5.7566 million.

The company recently announced that its self-developed global medical imaging data platform, iMedLoop, has officially gone live. iMedLoop integrates the iMedImage medical imaging base model, the iMedStudio intelligent annotation tool, and the iMedMaaS online model training and publishing platform, creating a complete closed loop around medical data aggregation and governance, intelligent annotation, model training, model publishing, and clinical application.

Notably, DIAGENS-B has also reached cooperation agreements with dozens of institutions, including Hangzhou Data Group Co., Ltd., Legend Holdings Corporation, Wenzhou Municipal Health Commission, Zhengzhou People's Hospital, and the School of Mathematical and Physical Medicine at Zhejiang Normal University. These parties will leverage the platform to collaboratively advance data governance, algorithm innovation, model development, and clinical validation, building a comprehensive ecosystem for medical AI innovation. This initiative aims to explore new pathways for enhancing diagnostic and treatment capabilities, supporting the Healthy China initiative.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment